APOE and early-onset autosomal dominant Alzheimer disease: No changes were found in the EQ-5D-5L, whereas the patient-reported Quality of Life in Alzheimer's Disease (QoL-AD) showed a significant improvement in subjective quality of life for APOE-positive participants in the intervention group (+1.5/−0.0p, p=0.042).